---
figid: PMC4780427__nihms762257f2
figtitle: Phosphoinositide-3-kinase/protein kinase B/mammalian target of rapamycin
  (PI3K/AKT/mTOR or PAM) pathway promotes cell growth/proliferation and cell survival,
  and sustained metabolic activity
organisms:
- Mus musculus
- Rattus norvegicus
- Oryza sativa
- Citrus macrophylla
- Homo sapiens
- Gallus gallus
- Trypanosoma brucei
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4780427
filename: nihms762257f2.jpg
figlink: /pmc/articles/PMC4780427/figure/F2/
number: F2
caption: The phosphoinositide-3-kinase/protein kinase B/mammalian target of rapamycin
  (PI3K/AKT/mTOR or PAM) pathway promotes cell growth/proliferation and cell survival,
  and sustained metabolic activity. Many therapies exist to target the PAM pathway,
  however feedback loops intrinsic to the pathway make single target/single agent
  treatments less efficacious. Dual targeting therapies are gaining momentum in investigations.
  Because PAM activity regulates glycolysis, measuring PAM targeting drug efficacies
  by interrogating the tumor extracellular pH is possible.
papertitle: Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis
  as a Biomarker of Drug Efficacy.
reftext: Paul J Akhenblit, et al. J Cancer Sci Ther. 2016;8(1):20-29.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5882487
figid_alias: PMC4780427__F2
figtype: Figure
redirect_from: /figures/PMC4780427__F2
ndex: a276b820-df23-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4780427__nihms762257f2.html
  '@type': Dataset
  description: The phosphoinositide-3-kinase/protein kinase B/mammalian target of
    rapamycin (PI3K/AKT/mTOR or PAM) pathway promotes cell growth/proliferation and
    cell survival, and sustained metabolic activity. Many therapies exist to target
    the PAM pathway, however feedback loops intrinsic to the pathway make single target/single
    agent treatments less efficacious. Dual targeting therapies are gaining momentum
    in investigations. Because PAM activity regulates glycolysis, measuring PAM targeting
    drug efficacies by interrogating the tumor extracellular pH is possible.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
  - Crtc
  - LY294002
  - temsirolimus
  - ridaforolimus
  - AZD8055
  - MK-2206
  - AZD2014
  - lactic acid
  - rapamycin
  - sirolimus
---
